Elena Pastukhova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Elena Pastukhova has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Adrian Joseph Michel Bailey
Faculty of Medicine University of Ottawa Ottawa Ontario Canada
2 shared publications - Feras M. Ghazawi
Division of Dermatology, University of Ottawa, Ottawa, ON, Canada
2 shared publications - Heidi Oi-Yee Li
Division of Dermatology, The Ottawa Hospital, University of Ottawa, ON, Canada
2 shared publications - Marcus Guorui Tan
Division of Dermatology, University of Ottawa, Ottawa, ON, Canada
2 shared publications Quentin Nakonechny
Department of Medicine, Division of Dermatology, The Ottawa Hospital, University of Ottawa, Ottawa, Canada
2 shared publicationsAlison Spurr
Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada
1 shared publication
Latest Publications
- Open Access
- 28 May 2026
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
Retrospective Review of Pediatric Psoriasis and TNF-Inhibitor Induced Psoriasiform Disease in Patients With Skin of Color
Background: Psoriasis affects ~3% of the adult U.S. population, with known differences in prevalence, presentation, and treatment outcomes across racial and ethnic groups. In pediatric populations, disparities in psoriasis recognition may lead to delayed diagnosis and undertreatment, especially in patients with skin of color (SoC). Objectives: To compare clinical presentation and treatment patterns in pediatric patients with psoriasis with and without SoC at a single tertiary-care pediatric center. Methods: We conducted a retrospective, case–control cohort study of patients diagnosed with psoriasis (including TNF-associated psoriasis) before age 18 at SickKids Hospital (January 2008-March 2024). Inclusion criteria were systemic treatment before or after diagnosis of psoriasis and available photo documentation. Patients were stratified by skin phototype based on the Massey-Martin Scale for SoC. Demographics, clinical features, and treatment patterns were compared between SoC and non-SoC groups. Results: Among 115 patients, 42.6% were classified as SoC. Scalp involvement ( P = .008), inflammatory bowel disease ( P = .05), and arthritis were more common in non-SoC patients. SoC patients had a shorter time to diagnosis and were more likely to receive cyclosporine initially and methotrexate overall. Non-SoC patients had higher biologic use throughout care (77.2% vs 63.2%). Topical corticosteroids were the most prescribed treatment across both groups. Conclusions: Pediatric patients with and without SoC showed distinct trends in disease presentation and management. Differences in clinical presentation and medication use highlight the need for increased awareness of psoriasis manifestations in diverse skin types. Prospective studies with standardized assessment tools could help addressing the differences described in this study.
- 28 May 2026
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
Open AccessRetrospective Review of Pediatric Psoriasis and TNF-Inhibitor Induced Psoriasiform Disease in Patients With Skin of Color
Background: Psoriasis affects ~3% of the adult U.S. population, with known differences in prevalence, presentation, and treatment outcomes across racial and ethnic groups. In pediatric populations, disparities in psoriasis recognition may lead to delayed diagnosis and undertreatment, especially in patients with skin of color (SoC). Objectives: To compare clinical presentation and treatment patterns in pediatric patients with psoriasis with and without SoC at a single tertiary-care pediatric center. Methods: We conducted a retrospective, case–control cohort study of patients diagnosed with psoriasis (including TNF-associated psoriasis) before age 18 at SickKids Hospital (January 2008-March 2024). Inclusion criteria were systemic treatment before or after diagnosis of psoriasis and available photo documentation. Patients were stratified by skin phototype based on the Massey-Martin Scale for SoC. Demographics, clinical features, and treatment patterns were compared between SoC and non-SoC groups. Results: Among 115 patients, 42.6% were classified as SoC. Scalp involvement ( P = .008), inflammatory bowel disease ( P = .05), and arthritis were more common in non-SoC patients. SoC patients had a shorter time to diagnosis and were more likely to receive cyclosporine initially and methotrexate overall. Non-SoC patients had higher biologic use throughout care (77.2% vs 63.2%). Topical corticosteroids were the most prescribed treatment across both groups. Conclusions: Pediatric patients with and without SoC showed distinct trends in disease presentation and management. Differences in clinical presentation and medication use highlight the need for increased awareness of psoriasis manifestations in diverse skin types. Prospective studies with standardized assessment tools could help addressing the differences described in this study.
- 10 February 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (5) , 999-1000
Rubella vaccine-induced cutaneous granulomas
Dear Editor, A 53-year-old woman with a history of Sjögren’s syndrome presented with an 8-year history of enlarging pink papules that progressed to draining red–brown nodules, coalescing into plaques on the left upper arm (Figure 1a). A large excision did not remit the process and demonstrated suppurative granulomatous folliculitis on histopathology (Figure 1b). Two years before disease onset, she received measles–mumps–rubella (MMR) reimmunization to the affected arm. Fresh lesional tissue biopsy identified rubella genotype 1A, matching the vaccine strain. Rubella virus-induced cutaneous granulomas are characterized by the persistence of live virus in dermal tissue.1 Differential diagnoses include superficial granulomatous pyoderma gangrenosum, granuloma annulare, sarcoidosis, deep fungal and mycobacterial infections. Elena Pastukhova (Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Validation, Visualization, Writing—original draft, Writing—review & editing [equal]), Annie Langley (Data curation, Investigation [equal]), Yvette Miller-Monthrope (Data curation, Validation, Writing—review & editing [equal]), and David Croitoru (Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing—original draft, Writing—review & editing [equal]).
- 10 February 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (5) , 999-1000
Rubella vaccine-induced cutaneous granulomas
Dear Editor, A 53-year-old woman with a history of Sjögren’s syndrome presented with an 8-year history of enlarging pink papules that progressed to draining red–brown nodules, coalescing into plaques on the left upper arm (Figure 1a). A large excision did not remit the process and demonstrated suppurative granulomatous folliculitis on histopathology (Figure 1b). Two years before disease onset, she received measles–mumps–rubella (MMR) reimmunization to the affected arm. Fresh lesional tissue biopsy identified rubella genotype 1A, matching the vaccine strain. Rubella virus-induced cutaneous granulomas are characterized by the persistence of live virus in dermal tissue.1 Differential diagnoses include superficial granulomatous pyoderma gangrenosum, granuloma annulare, sarcoidosis, deep fungal and mycobacterial infections. Elena Pastukhova (Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Validation, Visualization, Writing—original draft, Writing—review & editing [equal]), Annie Langley (Data curation, Investigation [equal]), Yvette Miller-Monthrope (Data curation, Validation, Writing—review & editing [equal]), and David Croitoru (Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing—original draft, Writing—review & editing [equal]).
- Open Access
- 16 September 2024
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 192 (1) , 175-177
Sexual dysfunction following retinoid treatment: a systematic review
Despite product monograph warnings of post-retinoid sexual dysfunction (PRSD) for isotretinoin and recent policy decisions regarding the safety of isotretinoin, this study demonstrates that there remains conflicting and low-quality evidence on this topic and it is not possible to ascertain causation between retinoids and PRSD. Dermatologists and patients should be aware of the conflicting data regarding sexual dysfunction associated with systemic retinoid therapy. Routine screening for sexual side-effects during systemic retinoid treatment may be reasonable, as patients are less likely to self-disclose sexual health concerns.
- 16 September 2024
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 192 (1) , 175-177
Open AccessSexual dysfunction following retinoid treatment: a systematic review
Despite product monograph warnings of post-retinoid sexual dysfunction (PRSD) for isotretinoin and recent policy decisions regarding the safety of isotretinoin, this study demonstrates that there remains conflicting and low-quality evidence on this topic and it is not possible to ascertain causation between retinoids and PRSD. Dermatologists and patients should be aware of the conflicting data regarding sexual dysfunction associated with systemic retinoid therapy. Routine screening for sexual side-effects during systemic retinoid treatment may be reasonable, as patients are less likely to self-disclose sexual health concerns.
- Open Access
- 23 January 2024
- Published by Elsevier in JAAD Case Reports
- Vol. 45, 62-65
Chasing shadows: A series of tumoral melanosis mimicking melanoma
- 23 January 2024
- Published by Elsevier in JAAD Case Reports
- Vol. 45, 62-65
Open AccessChasing shadows: A series of tumoral melanosis mimicking melanoma
- Open Access
- 1 January 2024
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 12
New-onset of pemphigus following COVID-19 infection: A case report
COVID-19 has been implicated in various cutaneous autoimmune diseases. Pemphigus is a group of autoimmune blistering diseases that target the desmosomal complexes. Pemphigus triggered by COVID-19 has been seldom reported in the literature and remains both a diagnostic and therapeutic challenge. We report a case of COVID-19-induced pemphigus that responded well to prednisone and mycophenolate mofetil after 9 months from initial presentation. On histologic examination, both intercellular and basement membrane staining were noted. Indirect immunofluorescence staining was positive against the intercellular cement of the stratified epithelium from monkey esophagus. We hypothesize that COVID-19 stimulated the release of multiple pemphigus antigens, which resulted in the unusual histologic pattern reported in the present case. Although malignancy should be suspected when features of paraneoplastic pemphigus, such as basement membrane staining on direct immunofluorescence, are noted, it may also be a histologic pattern of pemphigus secondary to COVID-19 that clinicians may consider.
- 1 January 2024
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 12
Open AccessNew-onset of pemphigus following COVID-19 infection: A case report
COVID-19 has been implicated in various cutaneous autoimmune diseases. Pemphigus is a group of autoimmune blistering diseases that target the desmosomal complexes. Pemphigus triggered by COVID-19 has been seldom reported in the literature and remains both a diagnostic and therapeutic challenge. We report a case of COVID-19-induced pemphigus that responded well to prednisone and mycophenolate mofetil after 9 months from initial presentation. On histologic examination, both intercellular and basement membrane staining were noted. Indirect immunofluorescence staining was positive against the intercellular cement of the stratified epithelium from monkey esophagus. We hypothesize that COVID-19 stimulated the release of multiple pemphigus antigens, which resulted in the unusual histologic pattern reported in the present case. Although malignancy should be suspected when features of paraneoplastic pemphigus, such as basement membrane staining on direct immunofluorescence, are noted, it may also be a histologic pattern of pemphigus secondary to COVID-19 that clinicians may consider.
- Open Access
- 1 January 2023
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 11
Upadacitinib-induced paradoxical face and scalp dermatitis: A case report of a novel sequela
Atopic dermatitis is a chronic, pruritic inflammatory cutaneous condition that can carry significant morbidity. Severe or recalcitrant atopic dermatitis is often treated with immunosuppressants, biologics, or immune-modulating small molecule therapies. The Janus kinase–signal transducer and activator of transcription pathway is highly implicated in atopic dermatitis pathogenesis, and agents that inhibit Janus kinase signalling are new to the atopic dermatitis landscape. Upadacitinib is a JAK1 inhibitor that has a good safety and efficacy profile and is increasingly being prescribed for atopic dermatitis. We report a case of a 35-year-old male with extensive atopic dermatitis that initially improved significantly on upadacitinib, then after 6 months developed a severe crusted dermatitic eruption on the head favouring a seborrheic distribution. While the pathogenesis of this paradoxical reaction is unclear, this phenomenon may involve a shift to a more Th1/Th17-mediated immune response.
- 1 January 2023
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 11
Open AccessUpadacitinib-induced paradoxical face and scalp dermatitis: A case report of a novel sequela
Atopic dermatitis is a chronic, pruritic inflammatory cutaneous condition that can carry significant morbidity. Severe or recalcitrant atopic dermatitis is often treated with immunosuppressants, biologics, or immune-modulating small molecule therapies. The Janus kinase–signal transducer and activator of transcription pathway is highly implicated in atopic dermatitis pathogenesis, and agents that inhibit Janus kinase signalling are new to the atopic dermatitis landscape. Upadacitinib is a JAK1 inhibitor that has a good safety and efficacy profile and is increasingly being prescribed for atopic dermatitis. We report a case of a 35-year-old male with extensive atopic dermatitis that initially improved significantly on upadacitinib, then after 6 months developed a severe crusted dermatitic eruption on the head favouring a seborrheic distribution. While the pathogenesis of this paradoxical reaction is unclear, this phenomenon may involve a shift to a more Th1/Th17-mediated immune response.
- Open Access
- 1 January 2023
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 11
Segmental infantile hemangioma with milia: A case report
Milia are common in children. They are small, keratinizing cysts that arise either as primary epidermoid cysts or secondary to other dermatoses, trauma or certain medications. In the paediatric population, milia are most frequently congenital and resolve spontaneously. Infantile hemangiomas are relatively common in neonates. They typically arise within the first few weeks of life, undergo a proliferative phase in the first 6 months, then begin to involute at around 12 months of age. After involution, residual skin changes may be observed, such as telangiectasia, fibrofatty tissue and redundant skin. However, there is a gap in the literature regarding concomitant milia and infantile hemangiomas. We report a case of a 5-months-old female who presented with a large, segmental infantile hemangioma of the posterior neck with milia.
- 1 January 2023
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 11
Open AccessSegmental infantile hemangioma with milia: A case report
Milia are common in children. They are small, keratinizing cysts that arise either as primary epidermoid cysts or secondary to other dermatoses, trauma or certain medications. In the paediatric population, milia are most frequently congenital and resolve spontaneously. Infantile hemangiomas are relatively common in neonates. They typically arise within the first few weeks of life, undergo a proliferative phase in the first 6 months, then begin to involute at around 12 months of age. After involution, residual skin changes may be observed, such as telangiectasia, fibrofatty tissue and redundant skin. However, there is a gap in the literature regarding concomitant milia and infantile hemangiomas. We report a case of a 5-months-old female who presented with a large, segmental infantile hemangioma of the posterior neck with milia.
- Open Access
- 1 January 2023
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 11
Segmental Darier’s disease: A case report
Segmental Darier’s disease is an uncommon subtype of Darier’s genodermatosis, resulting from a mutation in the ATPase type 2 during early embryogenesis. It typically presents as a persistent, pruritic papular eruption following the lines of Blaschko. Histopathology of Darier’s disease demonstrates acantholysis, dyskeratosis, and corps ronds. First-line treatment includes topical retinoids, calcineurin inhibitors, and synthetic vitamin D analogues. Severe disease may require systemic therapy with oral retinoids, immunomodulators, magnesium, and low-dose naltrexone. Segmental Darier’s disease is important to recognize both clinically and histologically as it may resemble other acantholytic Blaschkolinear dermatoses and should be considered in individuals presenting with a chronic localized papular eruption in a Blaschkoid distribution. Herein, we present a case of a 48-year-old male with segmental Darier’s disease who improved significantly following acitretin treatment.
- 1 January 2023
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 11
Open AccessSegmental Darier’s disease: A case report
Segmental Darier’s disease is an uncommon subtype of Darier’s genodermatosis, resulting from a mutation in the ATPase type 2 during early embryogenesis. It typically presents as a persistent, pruritic papular eruption following the lines of Blaschko. Histopathology of Darier’s disease demonstrates acantholysis, dyskeratosis, and corps ronds. First-line treatment includes topical retinoids, calcineurin inhibitors, and synthetic vitamin D analogues. Severe disease may require systemic therapy with oral retinoids, immunomodulators, magnesium, and low-dose naltrexone. Segmental Darier’s disease is important to recognize both clinically and histologically as it may resemble other acantholytic Blaschkolinear dermatoses and should be considered in individuals presenting with a chronic localized papular eruption in a Blaschkoid distribution. Herein, we present a case of a 48-year-old male with segmental Darier’s disease who improved significantly following acitretin treatment.
- Open Access
- 26 October 2022
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 188 (3) , 440-441
Comorbid diagnosis of systemic lupus erythematosus in vitiligo: a systematic review and meta-analysis
Dear Editor, Vitiligo is an autoimmune pigmentary disorder of the skin with varying prevalence across ethnic groups.1 Studies have suggested an association between systemic lupus erythematosus (SLE) and vitiligo; however, a systematic evaluation of this association and its prevalence across populations are lacking. Herein, we aim to address this knowledge gap through a systematic review and meta-analysis.
- 26 October 2022
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 188 (3) , 440-441
Open AccessComorbid diagnosis of systemic lupus erythematosus in vitiligo: a systematic review and meta-analysis
Dear Editor, Vitiligo is an autoimmune pigmentary disorder of the skin with varying prevalence across ethnic groups.1 Studies have suggested an association between systemic lupus erythematosus (SLE) and vitiligo; however, a systematic evaluation of this association and its prevalence across populations are lacking. Herein, we aim to address this knowledge gap through a systematic review and meta-analysis.
- Open Access
- 30 June 2022
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 20, 100454
Risk factors and communities disproportionately affected by cervical cancer in the Russian Federation: A national population-based study
- 30 June 2022
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 20, 100454
Open AccessRisk factors and communities disproportionately affected by cervical cancer in the Russian Federation: A national population-based study